HCA Healthcare (HCA) Bonds Trading 1.5% Lower

An issue of HCA Healthcare Inc (NYSE:HCA) debt fell 1.5% against its face value during trading on Monday. The high-yield issue of debt has a 5% coupon and is set to mature on March 15, 2024. The debt is now trading at $103.00 and was trading at $104.00 last week. Price changes in a company’s debt in credit markets often predict parallel changes in its share price.

Several research firms recently weighed in on HCA. Zacks Investment Research cut HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Thursday, December 20th. Leerink Swann boosted their price objective on HCA Healthcare from $160.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 30th. UBS Group began coverage on HCA Healthcare in a research report on Thursday, November 15th. They set a “buy” rating and a $162.00 price objective for the company. Finally, Argus boosted their price objective on HCA Healthcare from $150.00 to $155.00 and gave the stock a “buy” rating in a research report on Tuesday, November 6th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and eighteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $148.43.

HCA traded down $0.87 on Monday, hitting $138.66. 1,008,119 shares of the stock traded hands, compared to its average volume of 1,587,261. HCA Healthcare Inc has a 52 week low of $93.03 and a 52 week high of $147.42. The firm has a market capitalization of $48.02 billion, a price-to-earnings ratio of 14.19, a P/E/G ratio of 1.16 and a beta of 0.80.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 29th. The company reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.59 by $0.40. The company had revenue of $12.27 billion for the quarter, compared to analyst estimates of $12.10 billion. HCA Healthcare had a negative return on equity of 91.25% and a net margin of 8.11%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the company posted $2.12 EPS. On average, equities research analysts expect that HCA Healthcare Inc will post 10.02 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 29th. Investors of record on Friday, March 1st will be given a dividend of $0.40 per share. The ex-dividend date is Thursday, February 28th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.35. This represents a $1.60 dividend on an annualized basis and a yield of 1.15%. HCA Healthcare’s dividend payout ratio is 14.33%.

In other HCA Healthcare news, SVP Kathryn A. Torres sold 820 shares of the company’s stock in a transaction on Tuesday, November 13th. The stock was sold at an average price of $142.36, for a total transaction of $116,735.20. Following the transaction, the senior vice president now owns 4,237 shares of the company’s stock, valued at approximately $603,179.32. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Deborah M. Reiner sold 466 shares of the company’s stock in a transaction on Tuesday, February 5th. The stock was sold at an average price of $139.07, for a total value of $64,806.62. Following the transaction, the senior vice president now directly owns 5,037 shares in the company, valued at approximately $700,495.59. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,809 shares of company stock worth $254,181. 2.80% of the stock is owned by corporate insiders.

A number of large investors have recently bought and sold shares of the business. Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $25,000. Moody National Bank Trust Division acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $27,000. Doyle Wealth Management acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $31,000. Trust Co. of Vermont lifted its stake in shares of HCA Healthcare by 165.3% in the 4th quarter. Trust Co. of Vermont now owns 329 shares of the company’s stock valued at $41,000 after purchasing an additional 205 shares during the period. Finally, Csenge Advisory Group acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at $48,000. 72.85% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “HCA Healthcare (HCA) Bonds Trading 1.5% Lower” was originally published by WKRB News and is the sole property of of WKRB News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.wkrb13.com/2019/02/12/hca-healthcare-hca-bonds-trading-1-5-lower.html.

HCA Healthcare Company Profile (NYSE:HCA)

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: Penny Stocks, Risk and Reward Factors

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply